Home » Topics » BioWorld Science

BioWorld Science
RSS

SPH-5030 demonstrates potent and selective activity in HER2-mutant cancer models

May 6, 2022

Betta Pharmaceuticals presents preclinical results for cancer candidates BPI-371153 and BPI-442096

May 6, 2022

Insilico Medicine nominates preclinical candidate targeting MAT2A for MTAP-deleted cancers

May 6, 2022

Turning Point and LaNova enter license agreement for LM-302 and collaboration on ADC programs

May 6, 2022

Platform delivers siRNA targeting VEGF intravitreally for diabetic retinopathy

May 6, 2022

Vertex Pharmaceuticals patents CFTR modulators

May 6, 2022

Kymera Therapeutics presents STAT-degrading PROTACs

May 6, 2022

CD38 inhibitors discovered at Napa Therapeutics, Buck Institute

May 6, 2022

Silverback Therapeutics synthesizes TGFR-1 inhibitors and antibody-drug conjugates

May 6, 2022

Enliven Therapeutics describes new Bcr-Abl kinase inhibitors

May 6, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...